Introduction: The relationship between ejaculatory frequency and ejaculatory latency time is under-investigated. Subjects and Methods: 120 healthy subjects were enrolled in a prospective randomized trial. Patients in group A engaged in sexual intercourse after a 10-day abstinence period for 3 months. Patients in group B engaged in sexual intercourse twice a week for 3 months. Ejaculation function was evaluated through the measurement of the intravaginal ejaculatory latency time (IELT) and through the premature ejaculation diagnostic tool (PEDT) at baseline and at the end of the study. Results: At the end of the study, mean IELT values in group A were significantly lower compared to baseline values. Results from the PEDT questionnaire at the end of the study demonstrated a significantly worse ejaculatory control and ability to delay ejaculation by patients in group A. Conclusions: Reduced ejaculatory frequency impairs ejaculation control.

Keywords:
Ejaculatory abstinence, Intravaginal ejaculatory latency time, Prospective randomized trial
1.
McKenna K: Ejaculation; in Knobil E, Neill J (eds): Encyclopedia of Reproduction. New York, Academic Press, 1999, pp 1002–1008.
2.
Giuliano F, Clément P: Physiology of ejaculation: emphasis on serotonergic control. Eur Urol 2005;48:408–417.
3.
Grenier G, Byers ES: Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sex Behav 1995;24:447–472.
4.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision: DSM-IV-TR. Washington, APA, 2000, p 554.
5.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A: The International Index of Erectile Function: a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–830.
6.
Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, Abraham L, Crossland A, Morris M: Development and validation of a premature ejaculation diagnostic tool. Eur Urol 2007;52:565–573.
7.
Waldinger MD: Recent advances in the classification, neurobiology and treatment of premature ejaculation. Adv Psychosom Med 2008;29:50–69.
8.
Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M: A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005;2:492–497.
9.
Shafik A, Shafik AA, El Sibai O, Shafik IA: Contractile activity of the prostate at ejaculation: an electrophysiologic study. Urology 2006;67:793–796.
10.
Carlsen E, Petersen JH, Andersson AM, Skakkebaek NE: Effects of ejaculatory frequency and season on variations in semen quality. Fertil Steril 2004;82:358–366.
11.
Trinchieri A, Magri V, Cariani L, Bonamore R, Restelli A, Garlaschi MC, Perletti G: Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Arch Ital Urol Androl 2007;79:67–70.
12.
Basile Fasolo C, Mirone V, Gentile V, Parazzini F, Ricci E: Andrology Prevention Week Centers; Italian Society of Andrology (SIA). Premature ejaculation: prevalence and associated conditions in a sample of 12,558 men attending the andrology prevention week 2001 – a study of the Italian Society of Andrology (SIA). J Sex Med 2005;2:376–382.
13.
Jacobsen SJ, Jacobson DJ, Rohe DE, Girman CJ, Roberts RO, Lieber MM: Frequency of sexual activity and prostatic health: fact or fairy tale? Urology 2003;61:348–353.
14.
Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA: Prevalence of chronic prostatitis in men with premature ejaculation. Urology 2001;58:198–202.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.